During a live event, Gary J. Schiller, MD, reviewed the diagnostics and characteristics of blastic plasmacytoid dendritic ...

Title: Efficacy and Safety of Pralsetinib in Patients with Advanced RET-fusion-positive NSCLC: Final Data from the Phase 1/2 ARROW Study Presenter: Eunice S. Wang, M.D. A post-hoc analysis of ...

Detailed price information for Biomea Fusion Inc (BMEA-Q) from The Globe and Mail including charting and trades.

Laboratory abnormalities include hyperglycemia, hypokalemia, leukocytosis, elevated CK, CK-MB, and troponin T levels in serum, bicarbonate consumption, and increased base deficit and blood lactate (16 ...

Panelists discuss how clinical trial data has shaped second-line therapy in polycythemia vera (PV), highlighting ruxolitinib ...

Objective Neonatal sepsis is a significant cause of morbidity and mortality, particularly in preterm infants. Despite its ...

The impact of calreticulin (CALR) mutations on long-term survival in essential thrombocythemia (ET) was examined in 299 patients whose diagnosis predated 2006.Mutational frequencies were 53% for ...

The prevalence of nephrolithiasis has been increasing in recent years, affecting appro­ximately 10% and 15% of the population. Kidney stone disease is associated with syste­mic comorbidities such as ...

Margaret Garnes (born 1970) Senior consultant, specialist in internal medicine and haematology. She has contributed the concept and written and revised the manuscript. The author has completed the ...

Evaluation was notable for lymphadenopathy, splenic lesions, pulmonary opacities, and leukocytosis. A diagnosis was made. Case Records of the Massachusetts General Hospital VOL. 391 NO. 22 Dec 05, ...